Insights into Company

McKesson Corporation ↗

Other Pharmaceuticals company

📍 United States NYSE MCK
Search companies

Key Metrics of McKesson Corporation

Revenue$309B▲ 11.7% YoYFY 2023
Operating income$3.9B▼ 10.8% YoY
Net profit$3.0B▼ 15.7% YoY
Shareholders' equity−$2.1B
Market cap$118BMCK · $1,012.34

About McKesson Corporation

Company details

Website
mckesson.com
Listed
NYSE: MCK

Company summary

Legal nameMcKesson Corporation
TickerMCK
ExchangeNYSE
CountryUnited States
SEC CIK0000927653
Listed since—
IndustryOther Pharmaceuticals
SectorOther Industries · Discovered Companies
Websitehttps://www.mckesson.com

US market & SEC filings

MCK · NYSE  ·  SEC CIK 0000927653

Last price · 23 Oct 2026 $1,012.34 −0.31%
Market cap$118B
P/E45.2On FY 2023 diluted EPS
Volume629,500
SectorHealth CareOther Pharmaceuticals
Country · IPOUnited States

MCK share price

Premium

Annual results (SEC EDGAR)

Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.

Sign in to continue See plans & pricing

Vendor checks & payment capacity

Sign in with access to company financials to review vendor evidence.

Registered office and contact

Registered officeIrving
GSTIN—
Email—
Websitehttps://www.mckesson.com
Members / shareholders—

Directors and key people

Directors are read from the MGT-7 annual return and AOC-4 signatories.

Similar companies

Charges (secured borrowings)

0 registered charges. Lenders, amounts and dates are part of the premium plan.

Statutory auditors

Auditors are read from the AOC-4 auditor's report section.

Group companies

Business activities and related parties

product distribution

Filings

No filings on record yet.